Zdrowie i gospodarka · 22/03/2022

FDA Establishes Public Docket to Gather Comments on Inactive Ingredient Database Updates

The FDA is seeking public input on how to prioritize the addition of maximum daily exposure information for inactive ingredients in its database and whether to remove dosage form information, a move aimed at improving transparency and safety